Immunome, Inc. · NASDAQ:IMNM

Rosett Max sold 60,000 Immunome, Inc. shares (Form 4)

Traded Jun 15, 2026 · Filed Jun 17, 2026

On Jun 15, 2026, Rosett Max (Chief Financial Officer) sold 60,000 Immunome, Inc. shares at US$18.23 for US$1.09M under a trading plan, leaving 54,037 shares. Filed Jun 17, 2026 (Form 4).

Sold
60,000 shares
Price
US$18.23
Value
US$1.09M
Holding after
54,037 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 15, 2026Common StockOption exercise60,000US$1.05114,037Direct
Jun 15, 2026Common StockSale60,000US$18.2354,037Direct

Source

View original at SEC

Related